Amarex logo

Biosimilars: Past, Present and Future

Facing steep increases in health care costs, U.S. legislators are making a concerted effort to find new ways to reduce the costs of biologics. Learn the regulatory history, new proposed development pathways, realities and myths about biosimilars, the politics involved and what the future holds.

Contact Us

Book a meeting or send us a message to talk to one of our experts.